Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

Recruiting

• Conditions: Cardiovascular Complication; Death; Cardiovascular; Attack; Cardiovascular Stroke; Liver Transplant; Complications

• Registration Number: NCT05895669
• Lead Sponsor: University of Campania "Luigi Vanvitelli"

Brief Summary

All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-02
• Study First Submitted: 2023-05-26
• Status Verified: 2023-06
• Study First Submitted QC: 2023-06-06
• Last Update Submitted: 2023-06-06
• Study First Posted: 2023-06-08
• Last Update Posted: 2023-06-08
• Primary Completion: 2024-05-02
• Study Completion: 2024-05-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center

Exclusion Criteria

• Missing Informed Consent Form
• Missing Contact Informations for Follow up

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiovascular death	From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months	death due to cardiac causes (myocardial infraction and/or stroke)
cardiovascular complication	From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months	fatal and non fatal myocardial infraction and/or stroke

Trial Locations

Locations (2)

Gragnano Hospital; 🇮🇹 Gragnano, SA, Italy

University of Campania Luigi Vanvitelli; 🇮🇹 Napoli, Italy